Navigation Links
Major Independent Study Underscores Utility of deCODE MI(TM) for Better Predicting Risk of Heart Attack, Informing Statin Therapy
Date:11/11/2008

eople from around the globe.

About deCODE

deCODE is a bio-pharmaceutical company developing drugs and DNA-based tests to improve the treatment, diagnosis and prevention of common diseases. Its lead therapeutic programs, which leverage the company's expertise in chemistry and structural biology, include DG041, an antiplatelet compound being developed for the prevention of arterial thrombosis; DG051 and DG031, compounds targeting the leukotriene pathway for the prevention of heart attack; and DG071 and a platform for other PDE4 modulators with therapeutic applications in Alzheimer's disease and other conditions. deCODE is a global leader in human genetics, and has identified key variations in the genome (SNPs) conferring increased risk of major public health challenges from cardiovascular disease to cancer. Based upon these discoveries deCODE has brought to market a growing range of DNA-based tests for gauging risk and empowering prevention of common diseases. Through its CLIA-registered laboratory, deCODE is offers deCODE T2(TM) for type 2 diabetes; deCODE AF(TM) for atrial fibrillation and stroke; deCODE MI(TM) for heart attack; deCODE ProCa(TM) for prostate cancer; deCODE Glaucoma(TM) for a major type of glaucoma; and deCODE BreastCancer, for the common forms of breast cancer. deCODE is delivering on the promise of the new genetics.(SM) Visit us on the web at http://www.decode.com; on our diagnostics site at http://www.decodediagnostics.com; for our pioneering personal genome analysis service, integrating the genetic variants included in these tests and those linked to another twenty common diseases, at http://www.decodeme.com; and on our blog at http://www.decodeyou.com.

Any statements contained in this presentation that relate to
'/>"/>

SOURCE deCODE genetics
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Dow AgroSciences and Exelixis Plant Sciences Announce Major Research Collaboration, Asset Purchase to Advance Gene Discovery and Validation
2. Weil Gotshal Wins Major Victory for Applera; Secures Summary Judgment Invalidating Three Patents
3. Radius Grants Major Pharmaceutical Company Exclusive Option to License BA058 for Osteoporosis
4. Genzyme Begins Major Expansion of Boston Manufacturing Facility
5. International Atomic Energy Agency and National Foundation for Cancer Research Launch Major Initiative to Improve Cancer Prevention and Treatments in Developing Countries
6. Forest Laboratories Lexapro and Generics-Dominated Fluoxetine Lead First-Line Therapy in the Treatment for Major Depression
7. Updated Drug Development Scrip Report Responds to the Pharma Industrys Major Changes
8. National Surgical Hospitals Acquires Majority Share of Houston-Area Surgery Center
9. Agendia Acquires Rights to the Discovery of a Major Drug Resistance Mechanism in Breast Cancer Potentially Leading to a Herceptin(R) Sensitivity Test
10. Bioponic Phytoceuticals to Roll Out Multiple Products to 1,000 Major Health Food Stores in the Western United States
11. SPO Medical Announces Major Sales Milestone

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)... MATEO, Calif., Nov. 24 ...cal company focused on developing and commercializ...ay that Anthony DiTonno, President and Chief Execu...Annual Piper Jaffray Health Care Conference, to be...tel in New York, New York. ,, Mr. DiTonno and ...
(Date:11/24/2009)...rimary efficacy endpoint has been met for patients...cancer, , QUEBEC CITY, Nov. 24 /PRNewswire-Fi...TSX: AEZ) (the "Company"), a global biopharmaceuti...ogy, today announced positive efficacy data from a... conjugate, AEZS-108 (formerly AN-152), in patient...
(Date:11/24/2009)...OD CITY, Calif., Nov. 24 ...nced that Randy Scott, Genomic Health,s Executive ...ffray Health Care Conference in New York City on T...To access the live and subsequently archived webca...ns section of Genomic Health,s website at http://...
(Date:11/24/2009)...TTLE, Nov. 24 Cell Thera...ent will present at the 21st Annual Piper Jaffray ...d December 1-2, 2009, at the New York Palace Hotel...at 11:00 a.m. Eastern Time in Holmes 1 (4th Floor)...be available at www.celltherapeutics.com , and it...
Breaking Biology Technology:NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Genomic Health to Present at Piper Jaffray Health Care Conference 2
..., Feb. 5 Transcept,Pharmaceuticals, Inc. announce...ief Executive Officer, is scheduled to present at ...in New York City on Monday, February 9, 2009 at 9:...presentation will be available at, http://www.tran...be available,for 30 days. , About Transcept Ph...
...In a video interview Andrew,Witty, GlaxoSmithKline... as,"robust" in a year that was "always going to b...ill cease providing EPS guidance, to allow a,focus...2008 as a strategic turning point for GSK Mr Witty...d take to really make this company,strong over the...
...icromet, Inc. (Nasdaq: MITI ), today announced t...l present at the BIO CEO and Investor Conference a... February 10, 2009. A simultaneous webcast of the ...bsite at www.micromet-inc.com . , , , Forum: ... February 10, 2009, Time: 2:15 pm, Eastern ...
Other Biology Technology:Transcept Pharmaceuticals to Present at 11th Annual BIO CEO & Investor Conference 2Micromet to Present at the BIO CEO and Investor Conference on February 10, 2009 2Micromet to Present at the BIO CEO and Investor Conference on February 10, 2009 3Micromet to Present at the BIO CEO and Investor Conference on February 10, 2009 4
(Date:11/23/2009)...he community-associated strain of the deadly super... most common antibioticsposes a far greater health...y into hospitals, according to a study in the Dece... The new threat is easily picked up in fitness cen...reased the overall burden of MRSA within hospitals...
(Date:11/23/2009)...e Wildlife Conservation Society says that western ...public of Congopart of the "mother lode" of more t...ing increasingly threatened by growing humans acti...ction of the swamp forests adjacent to the southwe... surveys confirmed that high densities of the grea...
(Date:11/23/2009)...A new study provides "incontrovertible evidence" t...and of Sumatra about 73,000 years ago deforested m...icenter, researchers report. , The volcano eject...he atmosphere, leaving a crater (now the world,s l...and 35 kilometers wide. Ash from the event has bee...
Breaking Biology News(10 mins):New study finds MRSA on the rise in hospital outpatients 2A year after discovery, Congo's 'mother lode' of gorillas remains vulnerable 2Supervolcano eruption -- in Sumatra -- deforested India 73,000 years ago 2Wolves lose their predatory edge in mid life new U of Minnesota study shows 60083 1Wolves lose their predatory edge in mid life new U of Minnesota study shows 60083 2NSF grant supports Rutgers Camden program for science majors 10524 1NSF grant supports Rutgers Camden program for science majors 10524 2NSF grant supports Rutgers Camden program for science majors 10524 3Bowel Disease Treatment May Raise Skin Cancer Risk 60079 1Bowel Disease Treatment May Raise Skin Cancer Risk 60079 2
...flying" lemur of Malaysia is the champion of all g...y, glide more than the length of two football fiel... on a tree trunk. , Researchers in Singapore, the...a, Berkeley, are discovering how these animals mov...with accelerometers. These devices, which measure ...
...cterium that harvests far-red light by making a ra...d its genetic secrets, according to a team of rese...e. , The researchers, from Arizona State Univers...n the current online edition (Feb. 4) of the Proce...hey have sequenced the genome of the cyanobacteriu...
...he availability of new genome sequencing technolog...test an intriguing hypothesis about how agricultur...n of plant pathogens. , Boris Vinatzer, assistant...d science in the College of Agriculture and Life S...lty Early Career Development (CAREER) award from t...
Other Biology News:Accelerometer backpacks aid study of gliding behavior in the 'flying' lemur 2Accelerometer backpacks aid study of gliding behavior in the 'flying' lemur 3Researchers decode genetics of rare photosynthetic bacterium 2Researchers decode genetics of rare photosynthetic bacterium 3Tomato pathogen genome may offer clues about bacterial evolution at dawn of agriculture 2
Rat Plasmin from Pel-Freez Biologicals
Mouse Anti-Human VEGF R3 / Flt-4 Monoclonal Antibody, Phycoerythrin Conjugated, Clone 54733 from R&D Systems
Goat Anti-Human GFR alpha-4 Polyclonal Antibody, Unconjugated from R&D Systems
Goat Anti-Rat CNTF R alpha Polyclonal Antibody, Unconjugated from R&D Systems
Biology Products: